36 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain regulatory
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain
424B5
SLNO
Soleno Therapeutics Inc
30 Mar 22
Prospectus supplement for primary offering
5:21pm
to recoup our investment in one or more planned products, even if our planned products obtain regulatory approval.
Our ability to commercialize our
424B5
sefxdol2sdc10 l0noek
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
cmo8zb 3biffvmjy778g
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
q3ho85rpsbag76t62
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
5sx xdokpv
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
aty2c6i9q6zccp0r
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
ciztfmlt1wuj2b2a
12 Apr 19
Prospectus supplement
4:41pm